NO20050781L - Cefalosporiner - Google Patents

Cefalosporiner

Info

Publication number
NO20050781L
NO20050781L NO20050781A NO20050781A NO20050781L NO 20050781 L NO20050781 L NO 20050781L NO 20050781 A NO20050781 A NO 20050781A NO 20050781 A NO20050781 A NO 20050781A NO 20050781 L NO20050781 L NO 20050781L
Authority
NO
Norway
Prior art keywords
cephalosporins
compound
formula
pharmaceuticals
substituents
Prior art date
Application number
NO20050781A
Other languages
English (en)
Inventor
Gerd Ascher
Josef Wieser
Werner Heilmayer
Michael Schranz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0216418A external-priority patent/GB0216418D0/en
Priority claimed from GB0222177A external-priority patent/GB0222177D0/en
Priority claimed from GB0223975A external-priority patent/GB0223975D0/en
Priority claimed from GB0223974A external-priority patent/GB0223974D0/en
Priority claimed from GB0223977A external-priority patent/GB0223977D0/en
Priority claimed from GB0223976A external-priority patent/GB0223976D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO20050781L publication Critical patent/NO20050781L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Forbindelse og anvendelse derav som. farmasøytisk middel.Forbindelse med formelen. eller med formelen. hvori substituentene har forskjellige betydninger, anvendelse som farmasøytiske midler.
NO20050781A 2002-07-15 2005-02-14 Cefalosporiner NO20050781L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0216418A GB0216418D0 (en) 2002-07-15 2002-07-15 Organic compound
GB0222177A GB0222177D0 (en) 2002-09-24 2002-09-24 Organic compounds
GB0223975A GB0223975D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223974A GB0223974D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223977A GB0223977D0 (en) 2002-10-15 2002-10-15 Organic compounds
GB0223976A GB0223976D0 (en) 2002-10-15 2002-10-15 Organic compounds
PCT/EP2003/007603 WO2004007505A1 (en) 2002-07-15 2003-07-14 Cephalosporins

Publications (1)

Publication Number Publication Date
NO20050781L true NO20050781L (no) 2005-02-14

Family

ID=30119477

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050781A NO20050781L (no) 2002-07-15 2005-02-14 Cefalosporiner

Country Status (23)

Country Link
US (1) US7485632B2 (no)
EP (1) EP1529050B1 (no)
JP (1) JP2005536499A (no)
KR (1) KR20050037553A (no)
CN (1) CN1678616A (no)
AR (1) AR040545A1 (no)
AT (1) ATE327239T1 (no)
AU (1) AU2003250056A1 (no)
BR (1) BR0312698A (no)
CA (1) CA2492373A1 (no)
CO (1) CO5680481A2 (no)
DE (1) DE60305506T2 (no)
EC (1) ECSP055538A (no)
ES (1) ES2268429T3 (no)
HK (1) HK1077299A1 (no)
IL (1) IL166120A0 (no)
MX (1) MXPA05000664A (no)
NO (1) NO20050781L (no)
PE (1) PE20040657A1 (no)
PL (1) PL373104A1 (no)
SI (1) SI1529050T1 (no)
TW (1) TW200422044A (no)
WO (1) WO2004007505A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189171A (ja) * 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd 新規なグアノシン三リン酸（ｇｔｐ）結合タンパク質共役型のレセプタ―タンパク質
JP6580590B2 (ja) * 2014-04-16 2019-09-25 シーカ・テクノロジー・アーゲー アミジン基またはグアニジン基を含有するシラン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5093989A (no) * 1973-10-25 1975-07-26
JPH11506429A (ja) 1995-05-11 1999-06-08 ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 抗細菌セファロスポリン類
GB0301938D0 (en) * 2003-01-28 2003-02-26 Biochemie Gmbh Organic compounds

Also Published As

Publication number Publication date
EP1529050A1 (en) 2005-05-11
DE60305506T2 (de) 2007-04-19
ES2268429T3 (es) 2007-03-16
AU2003250056A1 (en) 2004-02-02
TW200422044A (en) 2004-11-01
WO2004007505A1 (en) 2004-01-22
SI1529050T1 (sl) 2006-10-31
IL166120A0 (en) 2006-01-15
HK1077299A1 (en) 2006-02-10
JP2005536499A (ja) 2005-12-02
KR20050037553A (ko) 2005-04-22
PL373104A1 (en) 2005-08-08
ATE327239T1 (de) 2006-06-15
DE60305506D1 (de) 2006-06-29
CN1678616A (zh) 2005-10-05
CA2492373A1 (en) 2004-01-22
AR040545A1 (es) 2005-04-13
MXPA05000664A (es) 2005-04-25
US7485632B2 (en) 2009-02-03
EP1529050B1 (en) 2006-05-24
BR0312698A (pt) 2005-05-03
ECSP055538A (es) 2005-03-10
PE20040657A1 (es) 2004-11-08
US20050234233A1 (en) 2005-10-20
CO5680481A2 (es) 2006-09-29

Similar Documents

Publication Publication Date Title
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
ATE464307T1 (de) Mif-hemmer
RS52323B (en) 2'-FLUORO-2'-DEOKSITETRAHIDROURIDINI KAO INHIBITORI CITIDIN DEAMINAZE
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20054762L (no) Polymorphs of aripiprazole
TW200638930A (en) Acetylene derivatives
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
ATE433447T1 (de) Pyrimiidinverbindungen
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
SE0301653D0 (sv) Novel compounds
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20066055L (no) Pyridinderivater
NO20081042L (no) PPAR aktive forbindelser
NO20082497L (no) Diarylureaer for behandling av pulmonal hypertensjon
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
ATE445593T1 (de) Acetylenderivate
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
RS51616B (en) HETEROARYL UREE DERIVATIVES USEFUL TO INHIBIT CHK1
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
ES2335410T8 (es) Derivados de aminopropanol.
NO20070565L (no) Kinolin tiazolinoner med CDK1 antiproliferativ aktivitet
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
NO20044526L (no) Hemisterlinderivater og anvendelser derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application